1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Virtual-Integrated Twin for Autonomous Lifesaving (VITAL) is sponsored by Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO). The VITAL program seeks to develop continuously updating computational models of the cardiovascular system, known as digital twins.
These models integrate patient data with biological physics to predict outcomes in real-time, enabling clinicians to assess treatment options for acute injuries, bleeding events, shock, and chronic cardiovascular pathologies. The program focuses on creating both highly detailed models for accuracy and faster, AI-driven versions for real-time decision support, with rigorous validation.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Interested organizations, including non-profits and educational institutions, must submit a pre-proposal via the electronic Biomedical Research Application Portal (eBRAP) before being invited to submit a full proposal. DARPA strongly encourages teaming arrangements. Confirm the full requirements in the official notice before applying.
The current listing shows individual project budgets ranging from $700,000 to $5,000,000; specific award sizes and total funding levels are not disclosed and will be determined at the Government's discretion. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Virtual-Integrated Twin for Autonomous Lifesaving (VITAL) is funded by Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read articleDARPA pre-released Release 6 of its FY26 SBIR BAA on September 2, 2026. Five of the seven SBIR topics belong to the Biological Technologies Office, and four of those describe one continuous problem: keeping a casualty alive with no surgeon, no imaging, and no evacuation. Here are the award sizes, the Direct-to-Phase-II gates, and the sequencing DARPA is buying.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read article